IN2009DN05722A - - Google Patents
Download PDFInfo
- Publication number
- IN2009DN05722A IN2009DN05722A IN5722DEN2009A IN2009DN05722A IN 2009DN05722 A IN2009DN05722 A IN 2009DN05722A IN 5722DEN2009 A IN5722DEN2009 A IN 5722DEN2009A IN 2009DN05722 A IN2009DN05722 A IN 2009DN05722A
- Authority
- IN
- India
- Prior art keywords
- prostate cancer
- susceptibility
- determining
- variants
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8604 | 2007-02-07 | ||
| IS8654 | 2007-06-22 | ||
| PCT/IS2008/000003 WO2008096375A2 (en) | 2007-02-07 | 2008-02-07 | Genetic variants contributing to risk of prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009DN05722A true IN2009DN05722A (he) | 2015-07-24 |
Family
ID=39650503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5722DEN2009 IN2009DN05722A (he) | 2007-02-07 | 2008-02-07 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8865400B2 (he) |
| EP (2) | EP2522743A3 (he) |
| JP (1) | JP2010520745A (he) |
| CN (1) | CN102317470A (he) |
| AU (1) | AU2008212117B2 (he) |
| BR (1) | BRPI0807236A2 (he) |
| CA (1) | CA2677994A1 (he) |
| IL (1) | IL200197A (he) |
| IN (1) | IN2009DN05722A (he) |
| MX (1) | MX2009008461A (he) |
| NZ (1) | NZ579401A (he) |
| SG (1) | SG193026A1 (he) |
| WO (1) | WO2008096375A2 (he) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697360B2 (en) | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
| US20090226912A1 (en) * | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| KR101952965B1 (ko) | 2010-05-25 | 2019-02-27 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Ｂａｍｂａｍ：고처리율 서열분석 데이터의 병렬 비교 분석 |
| WO2012029080A1 (en) * | 2010-08-30 | 2012-03-08 | Decode Genetics Ehf | Sequence variants associated with prostate specific antigen levels |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
| CN103797120B (zh) * | 2011-09-16 | 2017-04-12 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| CN103060433B (zh) * | 2012-10-19 | 2014-12-03 | 卫生部北京医院 | 一种预测前列腺癌易感性的试剂盒和方法 |
| JP2016508026A (ja) | 2012-11-20 | 2016-03-17 | ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ | 前立腺癌を有する個体の予後診断方法 |
| KR101944927B1 (ko) | 2016-03-24 | 2019-02-07 | 서울대학교산학협력단 | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR102371655B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068667B1 (ko) * | 2019-02-28 | 2020-01-21 | 주식회사 프로카젠 | 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371654B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068666B1 (ko) * | 2019-02-28 | 2020-02-11 | 주식회사 프로카젠 | 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| CN110596060B (zh) * | 2019-09-12 | 2020-08-21 | 江南大学 | 一种检测前列腺特异性抗原的光谱分析中荧光传感器的构建方法及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| CA1215904A (en) | 1983-01-10 | 1986-12-30 | David E. Kohne | Method for detection identification and quantitation of non-viral organisms |
| US5288611A (en) | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL91501A (en) | 1988-09-02 | 1998-03-10 | Dyax Corp | Generation of a variegated library of mutant potential binding proteins and screening of said library for proteins with a desired binding activity |
| US5750373A (en) | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| EP0585287B1 (en) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199054T1 (de) | 1990-12-06 | 2001-02-15 | Affymetrix Inc A Delaware Corp | Verbindungen und ihre verwendung in einer binären synthesestrategie |
| ES2287206T3 (es) | 1991-03-01 | 2007-12-16 | Dyax Corporation | Proceso para el desarrollo de mini-proteinas de union. |
| AU662148B2 (en) | 1991-04-10 | 1995-08-24 | Scripps Research Institute, The | Heterodimeric receptor libraries using phagemids |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| EP0695941B1 (en) | 1994-06-08 | 2002-07-31 | Affymetrix, Inc. | Method and apparatus for packaging a chip |
| US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| CA2255774C (en) | 1996-05-29 | 2008-03-18 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US5925519A (en) * | 1996-06-03 | 1999-07-20 | The Regents Of The University Of California | Genetic alterations associated with prostate cancer |
| ATE409226T1 (de) | 1998-06-05 | 2008-10-15 | Serono Genetics Inst Sa | Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1) |
| US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| WO2000027864A1 (en) * | 1998-11-06 | 2000-05-18 | Myriad Genetics, Inc. | CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE |
| US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| WO2004028346A2 (en) | 2002-09-25 | 2004-04-08 | Amersham Biosciences (Sv) Corp. | Detection methods |
| US20050136407A1 (en) | 2003-12-19 | 2005-06-23 | Cramer Scott D. | Genetic polymorphisms in the prostate-specific antigen gene promoter |
| US20050255507A1 (en) | 2004-02-17 | 2005-11-17 | Jenkins Robert B | Cytogenetically determined diagnosis and prognosis of proliferative disorders |
| WO2006063285A2 (en) | 2004-12-10 | 2006-06-15 | Sequenom, Inc. | Methods for identifying risk of breast cancer or prostate cancer and treatments thereof |
| NZ563913A (en) * | 2005-05-18 | 2010-03-26 | Decode Genetics Ehf | Markers for prostate cancer in LD Block A on chromosome 8q24.21 |
| AU2007310412B2 (en) * | 2006-10-27 | 2013-02-14 | Decode Genetics Ehf. | Cancer susceptibility variants on Chr8q24.21 |
| US8697360B2 (en) * | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
-
2008
- 2008-02-07 CN CN2008800107105A patent/CN102317470A/zh active Pending
- 2008-02-07 SG SG2012008371A patent/SG193026A1/en unknown
- 2008-02-07 JP JP2009548801A patent/JP2010520745A/ja not_active Ceased
- 2008-02-07 CA CA002677994A patent/CA2677994A1/en not_active Abandoned
- 2008-02-07 MX MX2009008461A patent/MX2009008461A/es active IP Right Grant
- 2008-02-07 EP EP12160294.0A patent/EP2522743A3/en not_active Withdrawn
- 2008-02-07 NZ NZ579401A patent/NZ579401A/en not_active IP Right Cessation
- 2008-02-07 US US12/442,171 patent/US8865400B2/en not_active Expired - Fee Related
- 2008-02-07 IN IN5722DEN2009 patent/IN2009DN05722A/en unknown
- 2008-02-07 WO PCT/IS2008/000003 patent/WO2008096375A2/en active Application Filing
- 2008-02-07 EP EP08710289.3A patent/EP2115171B1/en active Active
- 2008-02-07 AU AU2008212117A patent/AU2008212117B2/en not_active Ceased
- 2008-02-07 BR BRPI0807236A patent/BRPI0807236A2/pt not_active IP Right Cessation
-
2009
- 2009-08-02 IL IL200197A patent/IL200197A/he not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2115171A2 (en) | 2009-11-11 |
| SG193026A1 (en) | 2013-09-30 |
| IL200197A0 (en) | 2010-04-29 |
| EP2115171B1 (en) | 2015-01-21 |
| US20100041037A1 (en) | 2010-02-18 |
| AU2008212117A1 (en) | 2008-08-14 |
| MX2009008461A (es) | 2009-08-17 |
| US8865400B2 (en) | 2014-10-21 |
| CN102317470A (zh) | 2012-01-11 |
| CA2677994A1 (en) | 2008-08-14 |
| AU2008212117B2 (en) | 2014-09-11 |
| WO2008096375A3 (en) | 2008-12-18 |
| EP2522743A3 (en) | 2013-08-07 |
| IL200197A (he) | 2014-07-31 |
| EP2522743A2 (en) | 2012-11-14 |
| NZ579401A (en) | 2012-03-30 |
| WO2008096375A2 (en) | 2008-08-14 |
| BRPI0807236A2 (pt) | 2019-09-24 |
| JP2010520745A (ja) | 2010-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009DN05722A (he) | ||
| AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
| MX2009011456A (es) | Aumento de la productividad de las plantas por combinacion de agentes quimicos con modificaciones transgenicas. | |
| GB2460769A (en) | Tle3 as a marker for chemotherapy | |
| MX340453B (es) | Biomarcadores para cancer de pulmon. | |
| MX340181B (es) | Plantas de pepino resistentes al mildiu velloso. | |
| WO2008154249A3 (en) | Gene expression markers of tumor resistance to her2 inhibitor treatment | |
| ATE522518T1 (de) | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe | |
| EP1864134A4 (en) | METHODS OF TREATING OR PREVENTING HORMONE-RESISTANT PROSTATE CANCER USING SMALL INTERFERING RNA SPECIFIC TO PROTOCADHERINE-PC, OR OTHER INHIBITORS OF PROTOCADHERINE-PC EXPRESSION OR ACTIVITY | |
| WO2009134487A3 (en) | Optimized methods for delivery of dsrna targeting the pcsk9 gene | |
| MY150542A (en) | Cmet inhibitors | |
| MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
| MX2011013243A (es) | Marcadores de riesgo para enfermedad cardiovascular. | |
| EP2516624A4 (en) | CELL LINE 3M | |
| MX2009007695A (es) | Compuestos complejos de carbohidrato de hierro. | |
| MX2011011431A (es) | Composicion para el tratamiento de cancer de prostata. | |
| MY156954A (en) | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES | |
| WO2012083969A3 (en) | Microrna for diagnosis of pancreatic cancer | |
| MX2009004167A (es) | Anticuerpos que enlazan epitopos cxcr7. | |
| MX337203B (es) | Novedosas moleculas inhbidoras de jnk. | |
| MX339300B (es) | Inhibidores de molecula pequeña de la activacion n-terminal del receptor de androgenos. | |
| LT2012062A (lt) | Kompozicijos, būdai ir susiję panaudojimai, skirti modifikuotos dnr skaldymui | |
| IN2014KN01062A (he) | ||
| MX2009006943A (es) | Procedimiento para la mejor utilizacion del potencial de produccion de plantas transgenicas. | |
| MX350807B (es) | Composiciones y metodos para el analisis de cancer de prostata. |